Treatment and Management of Women With Bleeding Disorders
Completed
Centers for Disease Control and Prevention
N/A
2001-01-01
The purpose of the study is to determine whether oral contraceptives, desmopressin acetate,
and/or tranexamic acid are effective in the treatment of women with menorrhagia who are
diagnosed with a bleeding disorder.
Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia
Completed
Ferring Pharmaceuticals
Phase 3
2007-05-01
The purpose of this study is to investigate the efficacy and safety of several doses of the
melt formulation of desmopressin in a broad population of adult patients with nocturia.
The objective of this study was to compare the single-dose relative bioavailability of TEVA
and Aventis Pharmaceuticals (DDAVP®) 0.2 mg desmopressin acetate tablets following a 0.8 mg
dose under fasting conditions.
DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty
Unknown status
University Hospitals Cleveland Medical Center
Phase 2
2013-12-01
This is study looking at the use of a medication, Desmopressin acetate (DDAVP), to reduce
bleeding, swelling, and bruising in patients undergoing cosmetic nose surgery. DDAVP is a
drug used in patients with bleeding disorders. It works by activating molecules in the blood
stream called platelets that promote clotting. In the study, participants who are have
cosmetic nose surgery (rhinoplasty) will be randomly assigned to receive or not receive
medication. Photographs taken before and shortly after surgery will be evaluated for the
amount of bruising and swelling. Patients with heart, lung, kidney, or liver problems are not
eligible to participate.
Minirin Versus Oxybutynin for Nocturnal Enuresis in Children
Completed
Hormozgan University of Medical Sciences
Phase 3
2013-07-01
Nocturnal enuresis is among the most common disorders in children. The aim of current study
was to compare the efficacy and safety of Minirin and oxybutynin for treatment of nocturnal
enuresis in children in Bandar Abbas in 2014.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
